Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elena Tuna-Aguilar"'
Autor:
Santiago Riviello Goya, Sergio Rodriguez-Rodriguez, Mario Meza-Meza, Juan Luis Ontiveros-Austria, Elena Tuna-Aguilar, Roberta Demichelis-Gomez, Sergio I Inclan-Alarcon, Elia Apodaca-Chavez
Publikováno v:
HemaSphere, Vol 7, p e19287e8 (2023)
Externí odkaz:
https://doaj.org/article/6acd56ea45664ab6bccf602ad66eed47
Autor:
Vania Tietsche de Moraes Hungria, Carlos Chiattone, Miguel Pavlovsky, Lina M. Abenoza, Gladys P. Agreda, Jorge Armenta, Celso Arrais, Oscar Avendaño Flores, Fernando Barroso, Ana L. Basquiera, Carmen Cao, Maria S. Cugliari, Alicia Enrico, Laura M. Foggliatto, Kenny M. Galvez, David Gomez, Alvaro Gomez, Daniel de Iracema, Danielle Farias, Lineth Lopez, William Armando Mantilla, Deborah Martínez, Maria Jose Mela, Carlos E. Miguel, Roberto Ovilla, Luis Palmer, Carolina Pavlovsky, Christian Ramos, Guillermina Remaggi, Rodrigo Santucci, Sergio Schusterschitz, Claudia Lucia Sossa, Elena Tuna-Aguilar, Jorge Vela, Telma Santos, Odin de la Mora, Gerardo Machnicki, Mariana Fernandez, Paula Barreyro
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-19 (2019)
PURPOSE: Limited information is available on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL) management in Latin America. The primary objective of the Hemato-Oncology Latin America (HOLA) study was to describ
Externí odkaz:
https://doaj.org/article/e1cf84fea5fb415293927848125b0db5
Publikováno v:
Gaceta Médica de México, Vol 157, Iss 93 (2021)
Externí odkaz:
https://doaj.org/article/6675de34cf564671b178a569a8cf1805
Publikováno v:
Gaceta Médica de México. 157
Autor:
Daniel Montante-Montes-de-Oca, Hilda Elizeth Hernández-Juárez, Antonio Olivas-Martinez, Elena Tuna-Aguilar, Olga Barrales-Benítez, Diana Aguilar-León
Publikováno v:
memo - Magazine of European Medical Oncology. 13:111-117
Epidemiology of polycythemia vera (PV) is derived from cohort studies in Western populations. PV studies in the Latin population are limited and have described a lower prevalence of JAK2 mutation. A retrospective cohort of 90 Mexican patients from a
Autor:
Hilda Elizeth Hernández-Juárez, Adrián Nuñez-Zuno, Diana León-Aguilar, Elena Tuna-Aguilar, Antonio Olivas-Martinez, Olga Barrales-Benitez, Daniel Montante-Montes de Oca, Eduardo Corona-Rodarte, Jesús Delgado-de la Mora
Publikováno v:
Blood research
Background Thrombotic events are well documented in primary erythrocytosis, but it is uncertain if secondary etiologies increase the risk of thrombosis. This study aimed to determine the causes of erythrocytosis and to identify its impact as a risk f
Autor:
Katherinee Morales-Chacón, Maria T Bourlon, Alvaro Aguayo, Aldo A. Acosta-Medina, Christianne Bourlon, Elena Tuna-Aguilar
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e299-e306
Additional cytogenetic abnormalities (ACA) in patients with chronic myeloid leukemia (CML) are related to an increased risk of treatment failure, leukemic progression, and decreased survival. Currently, there are scarce data available for the Latin A
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:e373-e380
Introduction Hemophagocytic lymphohistiocytosis (HLH) is a disorder caused by severe immune activation. There are no specific criteria to establish the diagnosis in adults; however, the HLH-04 criteria are among the most commonly used. The HScore is
Autor:
Elia Apodaca Chavez, Aurea Garcés-Martínez, Roberta Demichelis, Juan Rangel-Patiño, Elena Tuna-Aguilar
Publikováno v:
Blood. 138:1118-1118
Introduction. Paroxysmal nocturnal hemoglobinuria (PNH) is associated with thrombosis and bone marrow failure. Thrombosis is the leading cause of death and morbidity, with 29-44% of patients presenting at least one thrombotic episode during their dis
Autor:
Alfonso Alfredo Rivera Duarte, Elena Tuna Aguilar, Elena Sandoval Cartagena, Alejandra Armengol Alonso
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:532-538
Background Chronic myelomonocytic leukemia (CMML) is the most aggressive of chronic leukemias, with short overall survival and a high transformation rate to acute leukemia. We investigated the factors related to blastic transformation in a Mexican po